Clincosm LogoSign in Get a demo

follicular lymphoma grade 3b

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma Trial in China (Relmacabtagene

Not yet recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • +3 more
  • Relmacabtagene Autoleucel
  • +2 more
  • Guangzhou, Guangdong, China
  • +12 more
Oct 24, 2023

Lentiviral-based Gene-edited Immune Cell Therapy

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • Pell's lentiviral-based gene-edited immune cell therapy
  • Kaohsiung, Taiwan
  • +2 more
Oct 25, 2022

Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Large B-cell Lymphoma Trial in Kaohsiung, Taipei

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • CD19-targeted chimeric antigen receptor T-cell
  • Kaohsiung, Taiwan
  • +2 more
Oct 25, 2022

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed B-Cell Lymphoma Trial in Saint Louis (Mosunetuzumab,

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 14, 2022

B-ALL, B-cell Non Hodgkin Lymphoma, DLBCL Trial in Stanford (Fludarabine, Cyclophosphamide, CD22 CAR)

Recruiting
  • B-ALL
  • +3 more
  • Stanford, California
    Stanford Medical Center
Jan 14, 2022

Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3B Trial in Changchun (R-CDOP)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma Grade 3B
  • R-CDOP
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Sep 15, 2021

Diffuse Large B-cell Lymphoma, Follicular Lymphoma Grade 3B Trial in China (R-CEOP-70, R-CEOP-90, R-CHOP-50)

Unknown status
  • Diffuse Large B-cell Lymphoma
  • Follicular Lymphoma Grade 3B
  • Chongqing, Chongqing, China
  • +11 more
Nov 10, 2017